Medical devices, healthcare technology and the business of care
510(k) clearance · K260490

Ninenovo Blood Oxygen Ring (BORMB-01-6,BORMB-01-7,BORMB-01-8,BORMB-01-9,BORMB-01-10,BORMB-01-11,BORMB-01-12,BORMB-01-13,BORMB-01-14)

Shenzhen Ninenovo Technology Limited · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK260490

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 2, 2026 for K260490, the Ninenovo Blood Oxygen Ring, submitted by Shenzhen Ninenovo Technology Limited through correspondent Shenzhen Bosstar Consulting Company Limited. The device is a wireless, non-invasive finger-worn pulse oximeter under 21 CFR 870.2700 (Oximeter), Class II, product code DQA, with the Cardiovascular regulation medical specialty and an Anesthesiology review panel. The filing is a Traditional 510(k); clearance is not premarket approval.

The cleared models are BORMB-01-6 through BORMB-01-14, differing by inner diameter (16.5 mm to 23.1 mm) at a stated 7.8 mm width. The summary names the circul pro Ring (K221361) as primary predicate and the Oxiband (Checkme) O2 Pulse Oximeter (K191088) as reference device. Stated indications cover spot-check or continuous SpO2 and pulse rate collection via the index finger in adults, in hospitals and home settings, up to twelve hours in non-motion, well-perfused conditions, without alarms. The summary does not report accuracy results, so comparative performance remains unverified here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260490
Regulatory pathway
510(k) premarket notification
Product code
DQA
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Oximeter.

Product code
DQA
FDA device class
2

FDA decision timeline

  1. K260490 received

    Application receipt date recorded by FDA.

  2. K260490 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQA

Product / regulatory recordCompanyPathwayDecision dateSource
ANNE LimbK261870
Sibel Health510(k) clearanceNov 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Ninenovo Technology Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records